Takaya Ikeda

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Clinicopathological risk factors for local recurrence in oral squamous cell carcinoma

Souichi Yanamoto, Shigeto Yamada, Hidenori Takahashi et al. · International Journal of Oral and Maxillofacial Surgery · 2012 · 94 citations · Full text

Veterinary Medicine, Oncology, Oral Pathology +13

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer

Hiroki Izumi, Shingo Matsumoto, Jie Liu et al. · Nature · 2021 · 71 citations · Full text

Medicine, Cancer Biology, Oncology +16

A clinicopathological study of perineural invasion and vascular invasion in oral tongue squamous cell carcinoma

Yuki Matsushita, Souichi Yanamoto, Hiroshi Takahashi et al. · International Journal of Oral and Maxillofacial Surgery · 2015 · 58 citations · Full text

Dentistry, Oral Pathology, Oral Histopathology +15